BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1322031)

  • 1. Effect of immunostimulant therapy on acute viral myocarditis in an animal model.
    Sato Y; Maruyama S; Kawai C; Matsumori A
    Am Heart J; 1992 Aug; 124(2):428-34. PubMed ID: 1322031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of coxsackievirus B3 myocarditis by immunoactive peptide in an animal model.
    Sato Y; Matsumori A
    Clin Immunol Immunopathol; 1992 Oct; 65(1):65-9. PubMed ID: 1395125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of viral myocarditis with recombinant human leukocyte interferon alpha A/D in a murine model.
    Matsumori A; Crumpacker CS; Abelmann WH
    J Am Coll Cardiol; 1987 Jun; 9(6):1320-5. PubMed ID: 3034992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of viral myocarditis with ribavirin in an animal preparation.
    Matsumori A; Wang H; Abelmann WH; Crumpacker CS
    Circulation; 1985 Apr; 71(4):834-9. PubMed ID: 2982522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus.
    Yamada T; Matsumori A; Sasayama S
    Circulation; 1994 Feb; 89(2):846-51. PubMed ID: 8313574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cyclosporine on the immunopathogenesis of viral myocarditis in mice.
    Matoba Y; Matsumori A; Okada I; Ohkusa T; Kawai C
    Jpn Circ J; 1991 Apr; 55(4):407-16. PubMed ID: 1646340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encephalomyocarditis (EMC) virus-induced myocarditis by different virus variants and mouse strains.
    Hirasawa K; Han JS; Takeda M; Itagaki S; Doi K
    J Vet Med Sci; 1992 Dec; 54(6):1125-9. PubMed ID: 1335759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive effects of OK432 on murine acute myocarditis due to encephalomyocarditis virus.
    Yokoyama T; Kanda T; Suzuki T; Murata K
    Cardiovasc Drugs Ther; 1991 Apr; 5(2):471-80. PubMed ID: 1713056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of levamisole, an immunomodulator, upon murine encephalomyocarditis virus myocarditis.
    Kishimoto C; Takada H; Hiraoka Y; Kurokawa M; Ochiai H
    Heart Vessels; 1997; 12(2):67-73. PubMed ID: 9403310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic behavior of lymphocytes in experimental viral myocarditis: significance of T lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c-nu/nu mice.
    Kishimoto C; Kuribayashi K; Masuda T; Tomioka N; Kawai C
    Circulation; 1985 Jun; 71(6):1247-54. PubMed ID: 2986878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Viral infections in medicine. 4. Viral myocarditis and cardiomyopathy].
    Matsumori A; Kawai C
    Nihon Naika Gakkai Zasshi; 1988 Sep; 77(9):1351-4. PubMed ID: 2854544
    [No Abstract]   [Full Text] [Related]  

  • 12. French maritime pine bark extract inhibits viral replication and prevents development of viral myocarditis.
    Matsumori A; Higuchi H; Shimada M
    J Card Fail; 2007 Nov; 13(9):785-91. PubMed ID: 17996829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lobenzarit on murine acute viral myocarditis.
    Yokoyama T; Kanda T; Suzuki T; Murata K
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):403-7. PubMed ID: 1325832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil ameliorates the clinical and pathological course of murine myocarditis.
    Dong R; Liu P; Wee L; Butany J; Sole MJ
    J Clin Invest; 1992 Nov; 90(5):2022-30. PubMed ID: 1331179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis.
    Tanaka A; Matsumori A; Wang W; Sasayama S
    Circulation; 1994 Oct; 90(4):2051-5. PubMed ID: 7923693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prednisolone on acute viral myocarditis in mice.
    Tomioka N; Kishimoto C; Matsumori A; Kawai C
    J Am Coll Cardiol; 1986 Apr; 7(4):868-72. PubMed ID: 3007597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulating therapy in viral myocarditis: effects of tumour necrosis factor, interleukin 2 and anti-interleukin-2 receptor antibody in an animal model.
    Matsumori A; Yamada T; Kawai C
    Eur Heart J; 1991 Aug; 12 Suppl D():203-5. PubMed ID: 1655449
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic identification of lymphocyte subsets in experimental murine myocarditis with encephalomyocarditis virus. Different kinetics of lymphocyte subsets between the heart and the peripheral blood, and significance of Thy 1.2+ (pan T) and Lyt 1+, 23+ (immature T) subsets in the development of myocarditis.
    Kishimoto C; Kuribayashi K; Fukuma K; Masuda T; Tomioka N; Abelmann WH; Kawai C
    Circ Res; 1987 Nov; 61(5):715-25. PubMed ID: 2889539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.
    Zhang H; Yousef GE; Ouyang X; Archard LC
    Int J Exp Pathol; 1994 Apr; 75(2):99-110. PubMed ID: 8199011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus.
    Monrad ES; Matsumori A; Murphy JC; Fox JG; Crumpacker CS; Abelmann WH
    Circulation; 1986 May; 73(5):1058-64. PubMed ID: 3698228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.